Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
2.290
+0.040 (1.78%)
At close: Jun 18, 2026, 4:00 PM EDT
2.420
+0.130 (5.68%)
After-hours: Jun 18, 2026, 7:55 PM EDT
Intelligent Bio Solutions Revenue
Intelligent Bio Solutions had revenue of $1.06M in the quarter ending March 31, 2026, with 45.54% growth. This brings the company's revenue in the last twelve months to $3.91M, up 33.26% year-over-year. In the fiscal year ending June 30, 2025, Intelligent Bio Solutions had annual revenue of $3.05M, down -1.90%.
Revenue (ttm)
$3.91M
Revenue Growth
+33.26%
P/S Ratio
1.40
Revenue / Employee
$71,150
Employees
55
Market Cap
5.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.05M | -59.25K | -1.90% |
| Jun 30, 2024 | 3.11M | 1.85M | 147.58% |
| Jun 30, 2023 | 1.26M | 819.72K | 187.52% |
| Jun 30, 2022 | 437.15K | -1.54M | -77.93% |
| Jun 30, 2021 | 1.98M | 1.79M | 949.29% |
| Jun 30, 2020 | 188.74K | - | - |
| Jun 30, 2019 | - | - | - |
| Jun 30, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 19.57M |
| Beyond Air | 6.92M |
| Tenon Medical | 4.60M |
| Biomerica | 4.33M |
| ENvue Medical | 2.18M |
| Nexalin Technology | 275.58K |
| HeartSciences | 8.67K |
INBS News
- 3 days ago - Intelligent Bio Solutions Slides: Investor presentation - Filings
- 4 days ago - Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry - GlobeNewsWire
- 16 days ago - Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18 - GlobeNewsWire
- 18 days ago - Intelligent Bio Solutions initiates multi-site method comparison study - TheFly
- 18 days ago - Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions Quarterly report: Q3 2026 - Filings
- 5 weeks ago - Intelligent Bio Solutions Earnings release: Q3 2026 - Filings